← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2025-11-25

Drug application

FDA Application #
ANDA219924
Application type
Abbreviated New Drug Application (Generic)
Brand name
NOREPINEPHRINE BITARTRATE
Generic name
NOREPINEPHRINE BITARTRATE
Active ingredients
NOREPINEPHRINE BITARTRATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ANTHEA PHARMA
Manufacturer
Avenacy, LLC
First approval
2025-11-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown